Opicapone - Latest Advances

Parkinson Disease.

Journal: Continuum (Minneapolis, Minn.)

Published: August 01, 2025

Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies.

Journal: Journal of neurology

Published: August 01, 2025

Add-on therapies to levodopa improve pain modulation in Parkinson's disease with motor fluctuations: A prospective cohort study.

Journal: Parkinsonism & related disorders

Published: June 24, 2025

Real-World Use of COMT Inhibitors in the Management of Patients with Parkinson's Disease in Spain Who Present Early Motor Fluctuations: Interim Results from the REONPARK Study.

Journal: Brain sciences

Published: April 04, 2025

Opicapone in Parkinson's disease: a real-world, multicenter, retrospective study to identify patient characteristics for sustained treatment benefit.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: March 31, 2025

Opicapone in Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study.

Journal: Movement disorders clinical practice

Published: March 21, 2025

Opicapone for Parkinson's disease-related sleep disturbances: The OASIS clinical trial.

Journal: Journal of Parkinson's disease

Published: February 20, 2025

Opicapone to Treat Early Wearing-off in Parkinson's Disease Patients: The European Experience.

Journal: Movement disorders clinical practice

Published: February 05, 2025

Opicapone improves end-of-dose neuropsychiatric fluctuations in patients with Parkinson's disease.

Journal: Clinical parkinsonism & related disorders

Published: January 10, 2025

Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer's and Parkinson's Diseases.

Journal: Neurology international

Published: December 06, 2024

Clinical pharmacokinetics of levodopa and relevant add-on therapies for Parkinson's disease.

Journal: Expert opinion on drug metabolism & toxicology

Published: November 11, 2024

Update on Treatments for Parkinson's Disease Motor Fluctuations - An International Parkinson and Movement Disorder Society Evidence-Based Medicine Review.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: October 30, 2024

Filters

Parkinson Disease.

Parkinson Disease.

Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies.

Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies.

Add-on therapies to levodopa improve pain modulation in Parkinson's disease with motor fluctuations: A prospective cohort study.

Add-on therapies to levodopa improve pain modulation in Parkinson's disease with motor fluctuations: A prospective cohort study.

Real-World Use of COMT Inhibitors in the Management of Patients with Parkinson's Disease in Spain Who Present Early Motor Fluctuations: Interim Results from the REONPARK Study.

Real-World Use of COMT Inhibitors in the Management of Patients with Parkinson's Disease in Spain Who Present Early Motor Fluctuations: Interim Results from the REONPARK Study.

Opicapone in Parkinson's disease: a real-world, multicenter, retrospective study to identify patient characteristics for sustained treatment benefit.

Opicapone in Parkinson's disease: a real-world, multicenter, retrospective study to identify patient characteristics for sustained treatment benefit.

Opicapone in Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study.

Opicapone in Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study.

Opicapone for Parkinson's disease-related sleep disturbances: The OASIS clinical trial.

Opicapone for Parkinson's disease-related sleep disturbances: The OASIS clinical trial.

Opicapone to Treat Early Wearing-off in Parkinson's Disease Patients: The European Experience.

Opicapone to Treat Early Wearing-off in Parkinson's Disease Patients: The European Experience.

Opicapone improves end-of-dose neuropsychiatric fluctuations in patients with Parkinson's disease.

Opicapone improves end-of-dose neuropsychiatric fluctuations in patients with Parkinson's disease.

Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer's and Parkinson's Diseases.

Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer's and Parkinson's Diseases.

Clinical pharmacokinetics of levodopa and relevant add-on therapies for Parkinson's disease.

Clinical pharmacokinetics of levodopa and relevant add-on therapies for Parkinson's disease.

Update on Treatments for Parkinson's Disease Motor Fluctuations - An International Parkinson and Movement Disorder Society Evidence-Based Medicine Review.

Update on Treatments for Parkinson's Disease Motor Fluctuations - An International Parkinson and Movement Disorder Society Evidence-Based Medicine Review.